UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 116,667 shares of the healthcare conglomerate’s stock after selling 36 shares during the period. UnitedHealth Group accounts for 2.3% of Daymark Wealth Partners LLC’s holdings, making the stock its 9th biggest holding. Daymark Wealth Partners LLC’s holdings in UnitedHealth Group were worth $68,213,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Macroview Investment Management LLC raised its position in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. True Wealth Design LLC bought a new stake in UnitedHealth Group in the fourth quarter worth about $31,000. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. TD Cowen boosted their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Royal Bank of Canada raised their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company boosted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. HSBC boosted their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Stock Up 0.7 %

Shares of UnitedHealth Group stock traded up $3.95 on Wednesday, reaching $585.53. The company’s stock had a trading volume of 407,857 shares, compared to its average volume of 3,931,344. The company has a market capitalization of $540.69 billion, a price-to-earnings ratio of 35.55, a P/E/G ratio of 1.65 and a beta of 0.58. The firm’s fifty day simple moving average is $582.68 and its two-hundred day simple moving average is $529.13. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.14 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.